Notably, she had previously undergone right lung bulla resection surgery in 2019 for pneumothorax at another medical institution. A medical history was obtained, revealing a history of pneumothorax in ...

Axial and coronal unenhanced thin-slice chest HRCT scans (A and B, respectively) in a 25-year-old male cannabis smoker, showing a large (5 cm) bulla (white arrows), sharply demarcated by a thin wall ...

If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025Priority ...

Dupilumab, an interleukin-4 receptor antagonist, is expected to decrease the type 2 inflammation seen in bullous pemphigoid.

Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoidIf approved, Dupixent would be the first and only ...

Lung cancer in people who've never smoked is a growing concern, and it's alarming to see it become the fifth leading cause of cancer deaths worldwide. Air pollution is a significant risk factor ...

Lung cancer screening aims to find lung cancer early. This is when there are more treatment options available and there is the best chance of treating it successfully. In the UK, the National ...

As Sanofi and Regeneron await the FDA decision, a legal dispute between the partners over commercialisation details continues ...

The US Food and Drug Administration (FDA) has accepted for priority review the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults with bullous pemphigoid (BP).

Feb. 6, 2025 — Despite new medication, cystic fibrosis often leads to permanent lung damage. Researchers have discovered that the disease causes changes in the immune system early in life ...

Lung neuroendocrine cancers are lung cancers that develop in the neuroendocrine cells of the lung. Your healthcare team might also call them lung neuroendocrine neoplasms (lung NENs). But this means ...

Lung cancer is one of the most common types of cancer in the United States and a leading cause of cancer deaths. However, the timeline of how the disease progresses can vary based on several factors.